Amarin Corporation PLC EV/FCF

EV/FCF of AMRN for past 10 years: annual, quarterly and twelve month trailing (TTM) including EV/FCF growth rates and interactive chart. A valuation metric that measures the enterprise value of a stock compared to its free cash flow. Free cash flow is calculated as operating cash flow - capital expenditures and is a more accurate measure of a company's earning power than net income, as it's not easily manipulated. A low EV/FCF ratio can indicate undervaluation, while a high one might mean the growth expectations around the company are elevated. EV/FCF ratio can be compared to different companies in the same industry or to a company’s own historical valuation.


Highlights and Quick Summary

Current EV/FCF of Amarin Corporation PLC is -13.41 (as of December 31, 2021)
  • EV/FCF for the quarter ending June 30, 2022 was -1.47 (a -77.46% decrease compared to previous quarter)
  • Year-over-year quarterly EV/FCF decreased by -92.73%
  • Annual EV/FCF for 2021 was -13.41 (a -78.5% decrease from previous year)
  • Annual EV/FCF for 2020 was -62.37 (a -89.06% decrease from previous year)
  • Annual EV/FCF for 2019 was -570.13 (a 1294.21% increase from previous year)
Visit stockrow.com/AMRN for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical EV/FCF of Amarin Corporation PLC

Most recent EV/FCFof AMRN including historical data for past 10 years.

Interactive Chart of EV/FCF of Amarin Corporation PLC

Amarin Corporation PLC EV/FCF for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 -1.47 -6.53
2021 -13.41 -20.23 -20.14 -43.58 -13.41
2020 -62.37 155.63 128.79 31.36 -62.37
2019 -570.13 -134.77 -74.39 -52.63 -570.13
2018 -40.89 -73.84 -20.56 -28.61 -40.89
2017 -36.41 -19.8 -18.13 -14.73 -36.41
2016 -9.36 -8.8 -7.23 -4.7 -9.36
2015 -5.67 -6.15 -7.35 -8.07 -5.67
2014 -3.81 -3.11 -3.28 -2.57 -3.81
2013 -2.03 -5.41 -4.99 -6.94 -2.03

Business Profile of Amarin Corporation PLC

Sector: Healthcare
Industry: Biotechnology